Skip to main content
OpenTrials

Clinical trial condition

Gonadal Disorders

Explore clinical trials studying Gonadal Disorders. Study availability and eligibility vary by location and protocol.

4,158 public trials 780 recruiting studies
Refine in advanced search Browse all conditions

Gonadal Disorders trial results

Active, Not Recruiting

A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome

NCT05690386

Conditions
Cardiovascular Abnormalities, Cardiovascular Diseases, Chromosome Disorders, +17 more
Locations
  • Ascendis Pharma Investigational Site Palo Alto, California, United States
  • Ascendis Pharma Investigational Site San Diego, California, United States
  • Ascendis Pharma Investigational Site Aurora, Colorado, United States
  • Ascendis Pharma Investigational Site Orlando, Florida, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

National Cancer Institute "Cancer Moonshot Biobank"

NCT04314401

Conditions
Acute Myeloid Leukemia, Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, +98 more
Locations
  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis Daphne, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland Saraland, Alabama, United States
View all 150 locations
View Trial Details
Active, Not Recruiting

Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia

NCT04490915

Conditions
Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, Adrenogenital Syndrome, +16 more
Locations
  • Neurocrine Clinical Site Los Angeles, California, United States
  • Neurocrine Clinical Site San Diego, California, United States
  • Neurocrine Clinical Site San Francisco, California, United States
  • Neurocrine Clinical Site Aurora, Colorado, United States
View all 70 locations
View Trial Details
Active, Not Recruiting

Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)

NCT04152499

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +48 more
Locations
  • Los Angeles Hematology Oncology Medical Group Glendale, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
  • START MidWest Grand Rapids, Michigan, United States
View all 109 locations
View Trial Details
Active, Not Recruiting

PF-07104091 as a Single Agent and in Combination Therapy

NCT04553133

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +27 more
Locations
  • Medical Oncology & Hematology Associates DBA Mission Cancer and Blood Clive, Iowa, United States
  • Des Moines Oncology Research Association Des Moines, Iowa, United States
  • Medical Oncology & Hematology Associates DBA Mission Cancer and Blood Des Moines, Iowa, United States
  • Medical Oncology & Hematology Associates DBA Mission Cancer and Blood Des Moines, Iowa, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)

NCT03393884

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Mitchell Cancer Institute (University of South Alabama) Mobile, Alabama, United States
  • Gynecologic Oncology Associates (Hoag Hospital) Newport Beach, California, United States
  • Innovative Clinical Research Whittier, California, United States
View all 21 locations
View Trial Details

Related conditions